Veterinary Medicines

Vitamin AD3E

Not authorised
  • Retinol palmitate
  • TOCOPHERYL ACETATE
  • Colecalciferol
Download as PDF

Product identification

Medicine name:
Vitamin AD3E
Active substance:
  • Retinol palmitate
  • TOCOPHERYL ACETATE
  • Colecalciferol
Target species:
  • Cattle (calf)
  • Cattle
  • Horse
  • Pig
  • Pig (weaned piglet)
  • Pig (suckling piglet)
  • Dog
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Retinol palmitate
    176.47
    milligram(s)
    /
    1.00
    millilitre(s)
  • TOCOPHERYL ACETATE
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Colecalciferol
    2.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle (calf)
      • Meat and offal
        259
        day
    • Cattle
      • Meat and offal
        259
        day
      • Milk
        5
        day
    • Horse
      • Meat and offal
        259
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        194
        day
    • Pig (weaned piglet)
      • Meat and offal
        194
        day
    • Pig (suckling piglet)
      • Meat and offal
        194
        day
  • Intramuscular use
    • Cattle (calf)
      • Meat and offal
        20
        day
    • Cattle
      • Meat and offal
        50
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        50
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        20
        day
    • Pig (suckling piglet)
      • Meat and offal
        10
        day
    • Pig (weaned piglet)
      • Meat and offal
        10
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11JA
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Surrendered
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 150306
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 30/05/2022
Download